• Home
  • News

Sichenzia Ross Ference LLP Represents Biotricity, Inc. in $50 Million At-The-Market Offering Facility

biotricity logo

Press Release – New York, NY – March 23, 2022 – Sichenzia Ross Ference LLP announced today that it represented Biotricity, Inc. (NASDAQ: “BTCY”), a medical diagnostic and consumer healthcare technology company, in a $50 million At-The-Market offering facility (“ATM”).

The shares were registered on BTCY’s Registration Statement on Form S-3 (File No. 333-255544) filed with the Securities and Exchange Commission on April 27, 2021, and declared effective by the SEC on May 4, 2021, and the prospectus supplement relating to the ATM filed with the SEC on March 22, 2022.

H.C. Wainwright acted as agent for the ATM.  

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia and David Manno, and associates Matt Siracusa and Rajiv Radia.

Sichenzia Ross Ference LLP
Latest posts by Sichenzia Ross Ference LLP (see all)